Arvinas (ARVN) EPS (Basic) Growth (5y) (2022 - 2026)
Arvinas (ARVN) EPS (Basic) Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn |
| 10 | Arvinas | 530.56 Mn | -84.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.31% |
| Dec 31, 2025 | 1.03% |
| Sep 30, 2025 | 10.92% |
| Jun 30, 2025 | -2.86% |
| Mar 31, 2025 | 31.28% |
| Dec 31, 2024 | 0.38% |
| Sep 30, 2024 | -4.80% |
| Jun 30, 2024 | 2.16% |
| Mar 31, 2024 | -16.05% |
| Dec 31, 2023 | -10.31% |
| Sep 30, 2023 | 54.77% |
| Jun 30, 2023 | 36.62% |
| Mar 31, 2023 | 48.00% |
| Dec 31, 2022 | 21.02% |
| Sep 30, 2022 | 18.80% |
| Jun 30, 2022 | 18.46% |
| Mar 31, 2022 | 18.93% |